Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2026-02-22 @ 4:53 PM
Study NCT ID:
NCT02314156
Status:
COMPLETED
Last Update Posted:
2023-02-22
First Post:
2014-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy
Sponsor:
Northwestern University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | BRCA1 Mutation Carrier | View |
| None | BRCA2 Mutation Carrier | View |
| None | Ductal Breast Carcinoma In Situ | View |
| None | Lobular Breast Carcinoma In Situ | View |
| None | Stage 0 Breast Cancer | View |
| None | Stage IA Breast Cancer | View |
| None | Stage IB Breast Cancer | View |
| None | Stage IIA Breast Cancer | View |
| None | Stage IIB Breast Cancer | View |
Keywords: